Veravas
Business Services · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
805 Las Cimas Pkwy Ste 150, Austin, Texa...Phone Number
(512) 837-2827Website
www.veravas.comRevenue
$5.7 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
2
1
1
About Veravas
Veravas is a company focused on transforming laboratory diagnostics through its patented VeraBIND technology, which enhances the detection of low-abundance biomarkers for early disease detection. Their solutions, including the VeraBIND Tau assay, are particularly aimed at identifying tau pathology associated with Alzheimer's disease. Veravas serves clinicians, researchers, and payers by providing advanced research solutions that improve assay sensitivity and reliability across various diseases. The company is dedicated to accelerating research and improving diagnostic accuracy through innovative sample preparation and analysis.Explore more
Veravas Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Veravas your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Veravas launches new products
Click to see if Veravas had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Veravas has new funding data
Earning: See what the market has to say on Veravas recently announced quarterly report
Check out if Veravas is spiking on competitors!
Check if Veravas has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Veravas
Veravas, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Veravas as Masked Content
Find 2 more new buyers
Compare Similar Companies to Veravas
Compare insights from companies similar to Veravas, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Veravas is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Veravas is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Veravas.
Veravas financials insights
Gather financial insights about Veravas, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Unspecified
$4M
Debt
$150K
2021
Debt
$198K
Veravas Tech Stack
A closer look at the technologies used by Veravas
See more technologies
Most Recent Scoops
Event
will be attending the 2022 AACC Annual Scientific Meeting + Clinical Lab Expo conference as an exhibitor. The event will occur from July 24 to July 28, 2022.
Open Position
Veravas is currently seeking a Chief Operating Officer. (Austin, TX)
Funding
Veravas has received an SBA PPP loan in the amount of $198,622 from First National Bank of Pennsylvania resulting in the retention of 7 jobs.
Funding
Veravas , Inc. has received an SBA PPP loan for $150,000-350,000 from First National Bank of Pennsylvania.
Partnership
Integration, Product Development, Clinical Systems
Veravas News & Media
Veravas Launches VeraBIND™ Tau - First Blood Test to Detect Alzheimer's-Related Tau Pathology
New non-invasive test offers 96% sensitivity and 90% specificity, empowering earlier and more accessible Alzheimer's detection AUSTIN, Texas, April 22, 2025 /PRNewswire/ -- Veravas, a leader in clinical diagnostics, today announced the general commercial availability of VeraBIND™ Tau, the...Veravas Completes Analytical Verification Study of the VeraBIND Tau Assay, a Groundbreaking Test to Measure Alzheimer's Tau Pathology in Blood
AUSTIN, Texas--(BUSINESS WIRE)--Veravas, a leading innovator in clinical diagnostics, today announced the results of an analytical verification study of its VeraBIND™ Tau assay, a next-generation test being co-developed with Phanes Biotech, an early-stage biotech company focused on treatments for neurodegenerative diseases, for the detection of Alzheimer’s disease (AD). The test is designed to detect and measure disease pathology to enable the diagnosis of AD at its earliest, most treatable staVeravas Partners with Phanes Biotech to Co-develop a Next-generation Blood-based Tau Pathology Test to Improve Alzheimer's Disease Detection
AUSTIN, Texas & MALVERN, Pa.--(BUSINESS WIRE)--Veravas, Inc., a leading innovator in clinical diagnostics, today announced a collaboration with Phanes Biotech to co-develop a blood-based Alzheimer’s disease (AD) tau pathology test. Phanes Biotech is an early-stage biotech company focused on treatments for neurodegenerative diseases. The companies are codeveloping a test that leverages Veravas’ proprietary VeraBIND™ technology with Phanes’ biological intellectual property on tau pathology to detVeravas Launches Groundbreaking VeraBIND Technology for Ultra-Sensitive Assays and Matrix Free Sample Analysis
Revolutionary bead-based technology enables reliable biomarker detection in challenging samples, transforming clinical diagnostic performance and research workflows AUSTIN, Texas, June 20, 2023 /PRNewswire/ -- Today, Veravas, a leading innovator in clinical diagnostics, announced the...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Veravas
Sign Up For FreeTo access detailed company insights
Veravas is a company focused on transforming laboratory diagnostics through its patented VeraBIND technology, which enhances the detection of low-abundance biomarkers for early disease detection. Their solutions, including the VeraBIND Tau assay, are particularly aimed at identifying tau pathology associated with Alzheimer's disease. Veravas serves... Read More
